Skip to main content

Advertisement

Open Peer Review Reports for: Prognostic and predictive value of clinical and biochemical factors in breast cancer patients with bone metastases receiving "metronomic" zoledronic acid

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
1 Dec 2010 Submitted Original manuscript
25 Apr 2011 Reviewed Reviewer Report - Herbert Yu
11 May 2011 Reviewed Reviewer Report - Shiuan Chen
22 Jun 2011 Author responded Author comments - Xi-Chun Hu
Resubmission - Version 2
22 Jun 2011 Submitted Manuscript version 2
13 Jul 2011 Reviewed Reviewer Report - Herbert Yu
2 Aug 2011 Author responded Author comments - Xi-Chun Hu
Resubmission - Version 3
2 Aug 2011 Submitted Manuscript version 3
22 Aug 2011 Reviewed Reviewer Report - Herbert Yu
6 Sep 2011 Author responded Author comments - Xi-Chun Hu
Resubmission - Version 4
6 Sep 2011 Submitted Manuscript version 4
15 Sep 2011 Author responded Author comments - Xi-Chun Hu
Resubmission - Version 5
15 Sep 2011 Submitted Manuscript version 5
Publishing
22 Sep 2011 Editorially accepted
22 Sep 2011 Article published 10.1186/1471-2407-11-403

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement